Literature DB >> 16765042

Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years.

Kathryn Alsop1, Leeanne Mead, Letitia D Smith, Simon G Royce, Andrea A Tesoriero, Joanne P Young, Andrew Haydon, Garry Grubb, Graham G Giles, Mark A Jenkins, John L Hopper, Melissa C Southey.   

Abstract

Somatic mutation of K-ras is known to be a common event in colorectal cancer tumourigenesis however its association with age at onset has not been widely explored. In this study, we have analyzed tumours from a population-based study of colorectal cancer diagnosed before the age of 45 years, in which cases had been previously screened for germ-line mismatch repair gene mutations and for microsatellite instability. We used a micro-dissection and sequencing approach to search for somatic K-ras mutations in codons 12, 13 and 61 in 101 early-onset colorectal cancers. Six (6%) somatic K-ras mutations were detected; five in codon 12 (4 G>T transitions and 1 G>A) and one in codon 13 (G>A transition). All codon 12 mutations were identified in microsatellite stable tumours and the codon 13 mutation was identified in a MSI-high tumour. Four cases with K-ras mutations had no reported family history of colorectal cancer and two had some family history of colorectal cancer. None were known to carry a germ-line mutation in hMSH2, hMLH1, hMSH6 or hPMS2. The role of somatic K-ras mutations in early-onset colorectal cancer carcinogenesis appears to be minor, in contrast to its significant role in colorectal cancer of later age of onset.

Entities:  

Mesh:

Year:  2006        PMID: 16765042     DOI: 10.1016/j.ejca.2006.02.023

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

1.  MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.

Authors:  María Dolores Giráldez; Francesc Balaguer; Luis Bujanda; Miriam Cuatrecasas; Jenifer Muñoz; Virginia Alonso-Espinaco; Mikel Larzabal; Anna Petit; Victoria Gonzalo; Teresa Ocaña; Leticia Moreira; José María Enríquez-Navascués; C Richard Boland; Ajay Goel; Antoni Castells; Sergi Castellví-Bel
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

2.  Expression of IARS2 gene in colon cancer and effect of its knockdown on biological behavior of RKO cells.

Authors:  Ling Zhong; Yi Zhang; Jing-Yu Yang; Liang-Fa Xiong; Tao Shen; Ya-Lian Sa; Yi-Ming O'Yang; Si-Hui Zhao; Jia-Yong Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

Authors:  Xinwei Hua; Amanda I Phipps; Andrea N Burnett-Hartman; Scott V Adams; Sheetal Hardikar; Stacey A Cohen; Jonathan M Kocarnik; Dennis J Ahnen; Noralane M Lindor; John A Baron; Polly A Newcomb
Journal:  J Clin Oncol       Date:  2017-06-15       Impact factor: 44.544

4.  Prediagnostic Physical Activity and Colorectal Cancer Survival: Overall and Stratified by Tumor Characteristics.

Authors:  Sheetal Hardikar; Polly A Newcomb; Peter T Campbell; Aung Ko Win; Noralane M Lindor; Daniel D Buchanan; Karen W Makar; Mark A Jenkins; John D Potter; Amanda I Phipps
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-14       Impact factor: 4.254

5.  Clinical and molecular characterization of early-onset colorectal cancer.

Authors:  Alexandra N Willauer; Yusha Liu; Allan A L Pereira; Michael Lam; Jeffrey S Morris; Kanwal P S Raghav; Van K Morris; David Menter; Russell Broaddus; Funda Meric-Bernstam; Andrea Hayes-Jordan; Winston Huh; Michael J Overman; Scott Kopetz; Jonathan M Loree
Journal:  Cancer       Date:  2019-03-11       Impact factor: 6.860

6.  Overexpression of GRK6 associates with the progression and prognosis of colorectal carcinoma.

Authors:  Ran Tao; Qiang Li; Xiaofei Gao; Lilin Ma
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

7.  The role of SMAD4 in early-onset colorectal cancer.

Authors:  S G Royce; K Alsop; A Haydon; L Mead; L D Smith; A A Tesoriero; G G Giles; M A Jenkins; J L Hopper; M C Southey
Journal:  Colorectal Dis       Date:  2009-01-27       Impact factor: 3.788

8.  Descriptive profile of PIK3CA-mutated colorectal cancer in postmenopausal women.

Authors:  Amanda I Phipps; Karen W Makar; Polly A Newcomb
Journal:  Int J Colorectal Dis       Date:  2013-06-01       Impact factor: 2.571

9.  Association between molecular subtypes of colorectal cancer and patient survival.

Authors:  Amanda I Phipps; Paul J Limburg; John A Baron; Andrea N Burnett-Hartman; Daniel J Weisenberger; Peter W Laird; Frank A Sinicrope; Christophe Rosty; Daniel D Buchanan; John D Potter; Polly A Newcomb
Journal:  Gastroenterology       Date:  2014-09-30       Impact factor: 22.682

10.  Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.

Authors:  Amanda I Phipps; Elizabeth Alwers; Tabitha Harrison; Barbara Banbury; Hermann Brenner; Peter T Campbell; Jenny Chang-Claude; Daniel Buchanan; Andrew T Chan; Alton B Farris; Jane C Figueiredo; Steven Gallinger; Graham G Giles; Mark Jenkins; Roger L Milne; Polly A Newcomb; Martha L Slattery; Mingyang Song; Shuji Ogino; Syed H Zaidi; Michael Hoffmeister; Ulrike Peters
Journal:  Gastroenterology       Date:  2020-02-20       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.